New treatments and new assessment instruments for Hidradenitis suppurativa-Reference-Cited by-同舟云学术

New treatments and new assessment instruments for Hidradenitis suppurativa

Published:2022-09 Issue:S1 Volume:31 Page:33-39
ISSN:0906-6705
Container-title:Experimental Dermatology
language:en
Short-container-title:Experimental Dermatology

Author:

van Straalen Kelsey R.¹²^ORCID,Ingram John R.²³,Augustin Matthias²⁴^ORCID,Zouboulis Christos C.²⁵^ORCID

Affiliation:

1. Department of Dermatology University of Michigan Ann Arbor Michigan USA

2. European Hidradenitis Suppurativa Foundation e.V. Dessau Germany

3. Department of Dermatology, Division of Infection & Immunity Cardiff University Cardiff UK

4. Institute for Health Care Services Research in Dermatology and Nursing University Hospital Medical Center Hamburg‐Eppendorf Hamburg Germany

5. Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg Dessau Germany

Publisher

Wiley

Subject

Dermatology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/exd.14609

Reference40 articles.

1. Hidradenitis suppurativa

2. Development of core outcome sets in hidradenitis suppurativa: systematic review of outcome measure instruments to inform the process

3. Severity and Area Score for Hidradenitis ( SASH ): a novel outcome measurement for hidradenitis suppurativa

4. Hidradenitis Suppurativa Area and Severity Index ( HASI ): a pilot study to develop a novel instrument to measure the physical signs of hidradenitis suppurativa

5. Hidradenitis Suppurativa Area and Severity Index Revised (HASI‐R): psychometric property assessment*

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of piperacillin/tazobactam in the treatment of Hidradenitis suppurativa;Journal of Dermatological Treatment;2024-08-05

2. Essentials of hidradenitis suppurativa: a comprehensive review of diagnostic and treatment perspectives;Annals of Medicine & Surgery;2024-07-01

3. Determinant Factors of Disease Severity for Patients With Hidradenitis Suppurativa Evaluated in a Spanish Hospital Over a 5-Year Period;Actas Dermo-Sifiliográficas;2024-07

4. Hidradenitis Supurativa, una actualización. Parte II: diagnóstico, clasificación y tratamiento;Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica;2024-06-27

5. Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials;British Journal of Dermatology;2024-03-12